참고문헌
- Ogrendik M. Effect of clarithromycin in patients with active rheumatoid arthritis. Current Med Res Opin 2007;23:515-22. https://doi.org/10.1185/030079906X167642
- Ogrendik M. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-months, randomized, double-blind, placebo-control trial. Clin Ther 2009;31:1754-64. https://doi.org/10.1016/j.clinthera.2009.08.014
- Stover DE, Mangino D. Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia? Chest 2005;128:3611-17. https://doi.org/10.1378/chest.128.5.3611
- Lee WS, Lee SI, LeeMS, et al. Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate. Korean J Intern Med 2016;31:779-87. https://doi.org/10.3904/kjim.2015.066
- Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. https://doi.org/10.1002/art.1780310302
- Wells G, Becker JC, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009;68:954-60. https://doi.org/10.1136/ard.2007.084459
- Inoue E, Yamanaka H, Hara M, et al. Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis 2007;66:407-9. https://doi.org/10.1136/ard.2006.054205
- Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med 2004;117(Suppl 9A):S5-11.
- Ogrendik M. Antibiotics for the treatment of rheumatoid arthritis. Int J Gen Med 2014;7:43-7.
- Kunicki PK, Sobieszczanska-Malek M. Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient. Ther Drug Monit 2005; 27:107-8. https://doi.org/10.1097/00007691-200502000-00020
- Suzuki Y, Homma M, Doki K, et al. Impact of CYP3A5 genetic gene polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects. Br. J Pharmacol 2008;66(1):154-5. https://doi.org/10.1111/j.1365-2125.2008.03162.x
- Ohe M, Kataoka H, Mukai M. A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids. Kaohsiung J Med Sci 2016;32:484-5. https://doi.org/10.1016/j.kjms.2016.04.007
- Ohe M, Bohgaki T. A case of adult-onset Still's disease treated with monitoring of serum tacrolimus levels. Bull Hosp Jt Dis 2015;73:213-6.